Literature DB >> 10194764

Determination of peptide contact points in the human angiotensin II type I receptor (AT1) with photosensitive analogs of angiotensin II.

S A Laporte1, A A Boucard, G Servant, G Guillemette, R Leduc, E Escher.   

Abstract

To identify ligand-binding domains of Angiotensin II (AngII) type 1 receptor (AT1), two different radiolabeled photoreactive AngII analogs were prepared by replacing either the first or the last amino acid of the octapeptide by p-benzoyl-L-phenylalanine (Bpa). High yield, specific labeling of the AT1 receptor was obtained with the 125I-[Sar1,Bpa8]AngII analog. Digestion of the covalent 125I-[Sar1,Bpa8]AngII-AT1 complex with V8 protease generated two major fragments of 15.8 kDa and 17.8 kDa, as determined by SDS-PAGE. Treatment of the [Sar1,Bpa8]AngII-AT1 complex with cyanogen bromide produced a major fragment of 7.5 kDa which, upon further digestion with endoproteinase Lys-C, generated a fragment of 3.6 kDa. Since the 7.5-kDa fragment was sensitive to hydrolysis by 2-nitro-5-thiocyanobenzoic acid, we circumscribed the labeling site of 125I-[Sar1,Bpa8]AngII within amino acids 285 and 295 of the AT1 receptor. When the AT1 receptor was photolabeled with 125I-[Bpa1]AngII, a poor incorporation yield was obtained. Cleavage of the labeled receptor with endoproteinase Lys-C produced a glycopeptide of 31 kDa, which upon deglycosylation showed an apparent molecular mass of 7.5 kDa, delimiting the labeling site of 125I-[Bpa1]AngII within amino acids 147 and 199 of the AT1 receptor. CNBr digestion of the hAT1 I165M mutant receptor narrowed down the labeling site to the fragment 166-199. Taken together, these results indicate that the seventh transmembrane domain of the AT1 receptor interacts strongly with the C-terminal amino acid of [Sar1, Bpa8]AngII interacts with the second extracellular loop of the AT1 receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194764     DOI: 10.1210/mend.13.4.0270

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  13 in total

1.  S-nitrosylation of cysteine 289 of the AT1 receptor decreases its binding affinity for angiotensin II.

Authors:  Patrice C Leclerc; Pascal M Lanctot; Mannix Auger-Messier; Emanuel Escher; Richard Leduc; Gaetan Guillemette
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

2.  Ligand-specific conformation of extracellular loop-2 in the angiotensin II type 1 receptor.

Authors:  Hamiyet Unal; Rajaganapathi Jagannathan; Manjunatha B Bhat; Sadashiva S Karnik
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

3.  Genetic code expansion and photocross-linking identify different β-arrestin binding modes to the angiotensin II type 1 receptor.

Authors:  Laurence Gagnon; Yubo Cao; Aaron Cho; Dana Sedki; Thomas Huber; Thomas P Sakmar; Stéphane A Laporte
Journal:  J Biol Chem       Date:  2019-09-17       Impact factor: 5.157

4.  Importance of N-glycosylation positioning for cell-surface expression, targeting, affinity and quality control of the human AT1 receptor.

Authors:  Pascal M Lanctot; Patrice C Leclerc; Martin Clément; Mannix Auger-Messier; Emanuel Escher; Richard Leduc; Gaétan Guillemette
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

5.  Preliminary biochemical characterization of the novel, non-AT1, non-AT2 angiotensin binding site from the rat brain.

Authors:  Vardan T Karamyan; Jason Arsenault; Emanuel Escher; Robert C Speth
Journal:  Endocrine       Date:  2010-04-13       Impact factor: 3.633

6.  Structure of the human angiotensin II type 1 (AT1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode.

Authors:  Dany Fillion; Jérôme Cabana; Gaétan Guillemette; Richard Leduc; Pierre Lavigne; Emanuel Escher
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

7.  The fifth transmembrane domain of angiotensin II Type 1 receptor participates in the formation of the ligand-binding pocket and undergoes a counterclockwise rotation upon receptor activation.

Authors:  Ivana Domazet; Stéphane S Martin; Brian J Holleran; Marie-Eve Morin; Patrick Lacasse; Pierre Lavigne; Emanuel Escher; Richard Leduc; Gaétan Guillemette
Journal:  J Biol Chem       Date:  2009-09-22       Impact factor: 5.157

8.  The second transmembrane domain of the human type 1 angiotensin II receptor participates in the formation of the ligand binding pocket and undergoes integral pivoting movement during the process of receptor activation.

Authors:  Ivana Domazet; Brian J Holleran; Stéphane S Martin; Pierre Lavigne; Richard Leduc; Emanuel Escher; Gaétan Guillemette
Journal:  J Biol Chem       Date:  2009-03-09       Impact factor: 5.157

9.  Activation induces structural changes in the liganded angiotensin II type 1 receptor.

Authors:  Martin Clément; Jérôme Cabana; Brian J Holleran; Richard Leduc; Gaétan Guillemette; Pierre Lavigne; Emanuel Escher
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

10.  Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain.

Authors:  Antony A Boucard; Simon S Sauvé; Gaétan Guillemette; Emanuel Escher; Richard Leduc
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.